8 Pharma Stocks Affected by New Drug Price Negotiation Rules
About a year ago, President Joe Biden signed the Inflation Reduction Act into law. Among the many things that law achieved was to give Medicare, for the first time, the ability to directly negotiate the prices it pays for some of the single-source drugs that it spends the most on each year.
Recently, the Centers for Medicare and Medicaid Services (CMS) published a list of the first 10 drugs that will be subject to price negotiations. The prices that come out of those talks are scheduled to take effect in 2026.
Image source: Getty Images.
Source Fool.com
China Medical System Holdings Ltd Aktie
0,84 €
1,82 %
